5Vote!
PR News Wire (Free subscription) | 11/23/2009
INCLINE VILLAGE, Nev., Nov. 23 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that NASDAQ has established November 27, 2009 as the ex-dividend date for its $200 million special dividend to stockholders resulting from the securitization transaction completed on November 2, 2009. The dividend will be paid on December 15, 2009 to all stockholders of record on the record...
3Vote!
The Intangible Economy (Free subscription) | 11/09/2009
While intangible asset securitization has been quiet, is it not extinct. Last week, PDL BioPharma, Inc. announced that it closed on $300 million securitization of some of its patents. From what I can tell, it looks like exactly the type...
4Vote!
GuruFocus Updates (Free subscription) | 11/09/2009
By 10qk. PDL BioPharma Inc. ( PDLI ) filed Quarterly Report for the period ended 2009-09-30. Read more » »
4Vote!
Trading Goddess Stock Blog! (Free subscription) | 11/09/2009
Investors love low priced stocks. Investors love dividends. What happens if you combine the two criteria? WallStreetNewsNetwork.com just came out with a list of over 25 stocks selling for less than $10 per share, with market caps over $250 million, and yields over 10% . Many of them were closed end funds, but several are businesses, such as Cedar Fair LP (FUN), the amusement park and water park company,...
5Vote!
Red Orbit (Free subscription) | 11/02/2009
INCLINE VILLAGE, Nev., Nov. 2 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that it closed on its previously disclosed $300 million securitization transaction intended to monetize certain of its antibody humanization patents and royalties.
5Vote!
Market Wire (Free subscription) | 10/29/2009
NEW DELHI, INDIA (MARKET WIRE) Analyst Choice has combined some of the best financial and technical minds worldwide to bring you an array of free quality equity research and reporting. Today we have begun in-depth reporting on our website evaluating the current market condition of General Steel Holdings Inc. (NYSE: GSI), KBR Inc. (NYSE: KBR), Ashford Hospitality Trust Inc. (NYSE: AHT), Cadbury plc...
4Vote!
PR News Wire (Free subscription) | 10/28/2009
INCLINE VILLAGE, Nev., Oct. 28 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that it has priced a $300 million securitization transaction intended to monetize certain of its antibody humanization patents and royalties.
5Vote!
PR News Wire (Free subscription) | 10/28/2009
INCLINE VILLAGE, Nev., Oct. 28 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today reported financial results for the third quarter ended September 30, 2009.
5Vote!
PR News Wire (Free subscription) | 10/27/2009
INCLINE VILLAGE, Nev., Oct. 27 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that the company will hold its conference call and webcast at 8:30 a.m. Eastern Time on Wednesday, October 28 to discuss its financial results for the third quarter of 2009 and provide a business update. The call and webcast will follow the release of the third quarter ended September 30,...
5Vote!
Red Orbit (Free subscription) | 10/27/2009
INCLINE VILLAGE, Nev., Oct. 27 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that the company will hold its conference call and webcast at 8:30 a.m.
5Vote!
PR News Wire (Free subscription) | 10/23/2009
INCLINE VILLAGE, Nev., Oct. 22 /PRNewswire-FirstCall/ --PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that the company will hold a conference call and webcast on Wednesday, October 28 at 4:30 p.m. Eastern Time to discuss its financial results for the third quarter of 2009 and provide a business update. The call and webcast will follow the release of the third quarter ended September 30,...
5Vote!
Red Orbit (Free subscription) | 10/23/2009
INCLINE VILLAGE, Nev., Oct. 22 /PRNewswire-FirstCall/ --PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that the company will hold a conference call and webcast on Wednesday, October 28 at 4:30 p.m.